<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Total gastrectomy and gastrointestinal reconstruction
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Total gastrectomy and gastrointestinal reconstruction
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Total gastrectomy and gastrointestinal reconstruction
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Pamela Hebbard, MD, FRCS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David I Soybel, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 20, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H465973398">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term "total gastrectomy" implies the complete removal of all gastric tissue. Total gastrectomy is the treatment of choice for certain gastric tumors.
        </p>
        <p>
         Perioperative considerations, surgical techniques for total gastrectomy and gastrointestinal reconstruction, and complications of total gastrectomy are reviewed here. Issues pertaining to partial gastrectomy are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/15161.html" rel="external">
          "Partial gastrectomy and gastrointestinal reconstruction"
         </a>
         .)
        </p>
        <p>
         The surgical management of invasive gastric cancer is discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer"
         </a>
         .)
        </p>
        <p>
         The gastroesophageal junction refers to the point of transition from the abdominal esophagus to the proximal stomach. Carcinomas arising at or near the gastroesophageal junction pose unique challenges, both in their ability to arise from esophageal or gastric mucosa and in the complexity of jointly resecting the esophagus and stomach. Gastroesophageal junction tumors are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/16226.html" rel="external">
          "Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas"
         </a>
         .)
        </p>
        <p>
         The surgical management of hereditary diffuse gastric cancer (cadherin-1 [
         <em>
          CDH1
         </em>
         ] mutation), both in the prophylactic setting and when invasive gastric cancer has been confirmed, is discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/8041.html" rel="external">
          "Surgical management of hereditary diffuse gastric cancer"
         </a>
         .)
        </p>
        <p>
         Laparoscopic gastrectomy for cancer is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/109436.html" rel="external">
          "Laparoscopic gastrectomy for cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465976596">
         <span class="h1">
          SURGICAL ANATOMY AND PHYSIOLOGY OF THE STOMACH
         </span>
         <span class="headingEndMark">
          —
         </span>
         The surgical anatomy of the stomach, including the anatomic divisions of the stomach (cardia, fundus, body, antrum, and pyloric sphincter (
         <a class="graphic graphic_figure graphicRef79793" href="/z/d/graphic/79793.html" rel="external">
          figure 1
         </a>
         )), blood supply, and lymphatic drainage, is reviewed elsewhere (
         <a class="graphic graphic_figure graphicRef56689" href="/z/d/graphic/56689.html" rel="external">
          figure 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15161.html" rel="external">
          "Partial gastrectomy and gastrointestinal reconstruction", section on 'Surgical anatomy and physiology of the stomach'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465974905">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Total gastrectomy is indicated in the treatment of certain gastric tumors. These include (see
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Total versus partial gastrectomy'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastric adenocarcinoma affecting the proximal stomach. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Proximal and esophagogastric junction tumors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastrointestinal stromal tumors affecting the proximal stomach, where a more limited resection is not technically feasible. (See
         <a class="medical medical_review" href="/z/d/html/7727.html" rel="external">
          "Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type 3 or 4 gastric carcinoid affecting the proximal stomach. (See
         <a class="medical medical_review" href="/z/d/html/2615.html" rel="external">
          "Staging, treatment, and post-treatment surveillance of non-metastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors", section on 'Stomach'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hereditary diffuse gastric cancer (
         <em>
          CDH1
         </em>
         mutation), both in the prophylactic setting and when invasive gastric cancer has been confirmed. (See
         <a class="medical medical_review" href="/z/d/html/8041.html" rel="external">
          "Surgical management of hereditary diffuse gastric cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Signet ring carcinoma, a diffuse form of gastric carcinoma, may benefit from total gastrectomy due to this tumor's diffuse submucosal spread and difficulty in obtaining clear margins with subtotal gastrectomy. (See
         <a class="medical medical_review" href="/z/d/html/2513.html" rel="external">
          "Clinical features, diagnosis, and staging of gastric cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Benign indications for total gastrectomy are rare but include hemorrhagic gastritis that has failed medical and endoscopic management and intractable symptoms related to altered gastric physiology in patients who have undergone partial gastrectomy and reconstruction. (See
         <a class="medical medical_review" href="/z/d/html/15170.html" rel="external">
          "Management of stress ulcers", section on 'Subtotal or total gastrectomy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H465973907">
         <span class="h2">
          Contraindications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Total gastrectomy should not be performed under the following circumstances:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with metastatic disease who are asymptomatic or minimally symptomatic should not undergo total gastrectomy, unless performed in the context of a clinical trial. The only published randomized controlled trial of chemotherapy versus surgery plus chemotherapy failed to show any benefit in adding surgery to the treatment plan [
         <a href="#rid1">
          1
         </a>
         ]. Furthermore, the primary treatment of metastatic gastric cancer is chemotherapy, and total gastrectomy (which is associated with significant morbidities) can delay or prevent the patient from receiving treatment. Symptoms of obstruction are best managed by stenting, bypass, distal feeding tube, or palliative care. (See
         <a class="medical medical_review" href="/z/d/html/2473.html" rel="external">
          "Initial systemic therapy for locally advanced unresectable and metastatic esophageal and gastric cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2523.html" rel="external">
          "Adjuvant and neoadjuvant treatment of gastric cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Total gastrectomy should not be performed when a partial gastrectomy would provide negative margins, due to the increased risk of complications associated with total gastrectomy compared with partial resection. The exception would be known or suspected hereditary diffuse gastric cancer, which mandates removal of the entire stomach because of the risk of a future malignancy in any gastric remnant. (See
         <a class="medical medical_review" href="/z/d/html/8041.html" rel="external">
          "Surgical management of hereditary diffuse gastric cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with significant medical comorbidities, particularly those with major cardiovascular and respiratory disease, may not be acceptable candidates for total gastrectomy, which is associated with significant morbidity and mortality. (See
         <a class="local">
          'Perioperative morbidity and mortality'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Since the patient can be expected to lose weight following total gastrectomy, total gastrectomy may not be appropriate for patients who are malnourished. Various clinical scoring systems based on biochemical factors such as albumin have been proposed to define malnutrition in the context of gastric cancer surgery [
         <a href="#rid2">
          2
         </a>
         ]. Some patients with malignancy-related malnutrition, particularly after neoadjuvant therapy, may become better candidates for resection following a period of nutritional supplementation [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2880.html" rel="external">
          "Overview of perioperative nutrition support", section on 'Preoperative nutrition support'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H465973914">
         <span class="h1">
          TUMOR STAGING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prior to total gastrectomy, the patient should undergo preoperative staging to assess the extent of disease, including abdominal imaging, upper endoscopy, and staging laparoscopy (only for adenocarcinoma).
        </p>
        <p class="headingAnchor" id="H2107228600">
         <span class="h2">
          Imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preoperative chest and abdominal computed tomography (CT) should be performed to rule out metastatic disease, which contraindicates gastrectomy [
         <a href="#rid4">
          4
         </a>
         ]. Positron emission tomography (PET) scanning is not routinely performed but may be used to evaluate equivocal findings on other imaging studies. Inconclusive results may need further focused imaging or staging laparoscopy to definitively confirm or rule out metastases. (See
         <a class="local">
          'Staging laparoscopy'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H87993553">
         <span class="h2">
          Endoscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preoperative endoscopic evaluation should be used to assess the location of the tumor and its proximity to the gastroesophageal junction. The position of the gastroesophageal junction and the presence of hiatal hernia should also be noted. Total gastrectomy in patients with a shortened esophagus may require extension of the incision into the thorax.
        </p>
        <p class="headingAnchor" id="H9699447">
         <span class="h2">
          Staging laparoscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients undergoing total gastrectomy for gastric adenocarcinoma, staging laparoscopy can be used to rule out metastatic disease, particularly carcinomatosis, and avoid unnecessary laparotomy. In one systematic review, staging laparoscopy changed management in 60 percent of patients with gastric cancer [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Whether all patients with adenocarcinoma require staging laparoscopy prior to total gastrectomy or just those with advanced disease is controversial. Most experts recommend staging laparoscopy for patients who have locally advanced disease (T3 or T4), have nodal metastasis (N+), or may require multivisceral resection [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
         The laparoscopy may be performed as a standalone procedure or just prior to the planned gastrectomy. As neoadjuvant chemotherapy becomes more commonly used in gastric cancer, staging laparoscopy is increasingly performed as a standalone procedure prior to the initiation of chemotherapy. This timing allows all involved to have information regarding the curability of the tumor prior to embarking on a treatment plan. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Staging laparoscopy'
         </a>
         .)
        </p>
        <p>
         The indications for staging laparoscopy and general procedural details for performing staging laparoscopy for digestive malignancies are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2513.html" rel="external">
          "Clinical features, diagnosis, and staging of gastric cancer", section on 'Staging laparoscopy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15106.html" rel="external">
          "Diagnostic staging laparoscopy for digestive system cancers"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465975300">
         <span class="h1">
          PREOPERATIVE PREPARATION
         </span>
        </p>
        <p class="headingAnchor" id="H711380199">
         <span class="h2">
          Medical risk assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Assessment of operative risk prior to gastric resection should identify the presence of other medical comorbidities, which may preclude resection. In general, patients undergoing total gastrectomy are older. In the United States, gastric cancer is most frequently diagnosed among people aged 65 to 74 years; the average age at diagnosis is 69 [
         <a href="#rid8">
          8
         </a>
         ]. Since most total gastric resections are performed under elective circumstances, there is adequate time for risk assessment and optimization of the patient's medical status. Preoperative medical assessment is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">
          "Evaluation of cardiac risk prior to noncardiac surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6917.html" rel="external">
          "Evaluation of perioperative pulmonary risk"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465975401">
         <span class="h2">
          Antibiotics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antibiotic prophylaxis is recommended for procedures that enter into the lumen of the gastrointestinal tract. (See
         <a class="medical medical_review" href="/z/d/html/13984.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection following gastrointestinal procedures in adults", section on 'Gastroduodenal procedures'
         </a>
         .)
        </p>
        <p>
         Appropriate antibiotic choices are given in the table (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ). Patients should receive intravenous antibiotics prior to the incision, and dosing should be repeated intraoperatively for cases lasting more than three hours [
         <a href="#rid9">
          9,10
         </a>
         ]. Randomized trials in patients undergoing gastrectomy (partial or total) have found no benefit for longer-duration postoperative antibiotics over perioperative (24 hour) dosing [
         <a href="#rid11">
          11,12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H87993827">
         <span class="h2">
          Bowel preparation and decontamination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although some surgeons routinely prepare the bowel prior to a total gastrectomy, such practice may not be necessary. Even if a part of the colon unexpectedly requires en bloc resection with a large gastric tumor, right colectomy can be done safely without mechanical bowel preparation.
        </p>
        <p>
         However, there may be a role for oral enteral decontamination [
         <a href="#rid13">
          13,14
         </a>
         ]. One trial that evaluated oral antibiotic decontamination prior to total gastrectomy randomly assigned 260 patients to placebo or oral decontamination with
         <a class="drug drug_general" data-topicid="9790" href="/z/d/drug information/9790.html" rel="external">
          polymyxin B
         </a>
         (100 mg),
         <a class="drug drug_general" data-topicid="10000" href="/z/d/drug information/10000.html" rel="external">
          tobramycin
         </a>
         (80 mg),
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         (125 mg), and amphotericin B (500 mg) four times per day orally from the day before the operation until postoperative day seven [
         <a href="#rid13">
          13
         </a>
         ]. On intention-to-treat analysis, significantly fewer esophagojejunostomy anastomotic leaks occurred in the oral decontamination group compared with the placebo group (2.9 versus 10.6 percent). The rate of pulmonary infection was also significantly lower among those who received oral decontamination (8.8 versus 22.3 percent). Mortality rates were not significantly different. Unfortunately, there was a high dropout rate during follow-up (55 of 260 patients). A subsequent smaller trial did not find a significant difference [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         Contemporary observational studies in gastrointestinal surgery reported low anastomotic leak rate with oral decontamination [
         <a href="#rid15">
          15
         </a>
         ], but no newer trials have been reported. Additional well-designed trials will be needed before routine oral decontamination can be recommended for gastric cancer surgery.
        </p>
        <p class="headingAnchor" id="H465975440">
         <span class="h2">
          Thromboprophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients undergoing total gastrectomy for malignancy are at moderate-to-high risk for thromboembolism due to the nature and duration of the procedure, and pharmacologic prophylaxis is recommended (
         <a class="graphic graphic_table graphicRef83739" href="/z/d/graphic/83739.html" rel="external">
          table 2
         </a>
         ). We also place intermittent pneumatic compression devices on all patients prior to induction of anesthesia and continue their use until the patient is ambulatory. (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465975569">
         <span class="h1">
          GENERAL CONSIDERATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H3048707870">
         <span class="h2">
          Anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Total gastrectomy is performed under general anesthesia. For patients undergoing upper abdominal surgery, a transversus abdominis plane block or thoracic epidural anesthesia may simplify postoperative pain management and allow early postoperative mobilization, which may expedite the return of gastrointestinal function. (See
         <a class="medical medical_review" href="/z/d/html/121447.html" rel="external">
          "Abdominal nerve block techniques", section on 'Transversus abdominis plane (TAP) blocks'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89518.html" rel="external">
          "Epidural and combined spinal-epidural anesthesia: Techniques"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465975577">
         <span class="h2">
          Open versus minimally invasive total gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A total gastrectomy can be performed via an open or minimally invasive (laparoscopic or robotic) approach. Each approach is technically demanding and best performed by surgeons with advanced skills and training. Although various groups have reported satisfactory short- and long-term outcomes from laparoscopic total gastrectomy [
         <a href="#rid16">
          16,17
         </a>
         ], it should be noted that these reports are almost exclusively from high-volume cancer hospitals with extensive laparoscopic experience.
        </p>
        <p>
         Laparoscopic gastric cancer surgery is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/109436.html" rel="external">
          "Laparoscopic gastrectomy for cancer", section on 'Laparoscopic total gastrectomy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H376610163">
         <span class="h2">
          Margins of resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         For cancer resection, frozen sections at the proximal and distal gastric margins should be obtained to be certain that the margins are free of carcinoma and ensure an R0 resection. The required proximal resection margin determines if a subtotal or total gastrectomy is required, especially for midgastric tumors. A proximal margin of at least 3 cm for tumors with an expansive growth pattern and at least 5 cm for tumors with an infiltrative growth pattern was proposed in Asian guidelines [
         <a href="#rid18">
          18,19
         </a>
         ] and accepted by Western surgeons [
         <a href="#rid20">
          20
         </a>
         ]. A positive margin (R1) is associated with worse five-year survival (hazard ratio 2.06, 95% CI 1.61-2.65) [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
         When performing prophylactic gastrectomy for hereditary diffuse gastric cancer, the distal resection should be carried at least 1 cm distal to the pylorus. Frozen sections should be obtained of the proximal margin to confirm that all gastric mucosa has been removed. If gastric mucosa at the proximal resection is identified, a more proximal resection to esophageal mucosa is needed. Extension of the incision into the left thorax may be needed to achieve an adequate proximal margin in patients with a shortened esophagus. (See
         <a class="medical medical_review" href="/z/d/html/8041.html" rel="external">
          "Surgical management of hereditary diffuse gastric cancer", section on 'Margins of resection'
         </a>
         .)
        </p>
        <p>
         In the setting of gastrointestinal stromal tumors (GISTs), frozen section evaluation may not be necessary, since the gross margin is representative of the microscopic extent of the tumor.
        </p>
        <p class="headingAnchor" id="H465975690">
         <span class="h2">
          Extent of nodal dissection
         </span>
         <span class="headingEndMark">
          —
         </span>
         The required extent of lymphadenectomy depends on the tumor. In the rare instance of total gastrectomy for benign reasons, lymph node dissection is not required.
        </p>
        <p class="headingAnchor" id="H465976536">
         <span class="h3">
          Gastric adenocarcinoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         A formal lymph node dissection is required for invasive carcinomas, but the optimal extent of lymph node dissection remains controversial. The lymph node stations (
         <a class="graphic graphic_table graphicRef88420" href="/z/d/graphic/88420.html" rel="external">
          table 3
         </a>
         ) are grouped according to location (
         <a class="graphic graphic_figure graphicRef88422" href="/z/d/graphic/88422.html" rel="external">
          figure 3
         </a>
         ) and follow the extent of lymph node dissection (D1 through D3). (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Extent of lymph node dissection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15161.html" rel="external">
          "Partial gastrectomy and gastrointestinal reconstruction", section on 'Lymph node dissection'
         </a>
         .)
        </p>
        <p>
         Currently, a D2 dissection is the standard approach in Eastern countries (eg, Japan) [
         <a href="#rid18">
          18
         </a>
         ] and the recommended approach in experienced centers in the West [
         <a href="#rid7">
          7
         </a>
         ]. Compared with D1 dissection, which is the minimal accepted standard for cancer surgery, D2 dissection is associated with fewer local recurrences (12 versus 22 percent), regional recurrences (13 versus 19 percent), and cancer-related deaths (37 versus 48 percent) at 15 years [
         <a href="#rid22">
          22
         </a>
         ]. Although D2 dissection is associated with higher morbidity, mortality, and reoperation rate, such detriments were largely attributed to adjacent organ resection (ie, distal pancreatectomy and splenectomy), which is not included in the modern D2 dissection. Lymph node dissections that are more radical than D2 (eg, D2 plus paraaortic nodes, D3, or D4) should not be performed routinely, as randomized trials fail to show a survival benefit for more aggressive surgery [
         <a href="#rid23">
          23-26
         </a>
         ]. Regardless of type of lymph node dissection, a minimum of 16 lymph nodes should be harvested to ensure accurate staging of the patient [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         A detailed description of the definitions of the extent of lymph node dissections for gastric cancer is provided elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Extent of lymph node dissection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9699781">
         <span class="h3">
          Gastrointestinal stromal tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         No lymph node dissection is required for GISTs, as lymph node metastases are rare.
        </p>
        <p class="headingAnchor" id="H9699788">
         <span class="h3">
          Type 3 or 4 gastric carcinoid
         </span>
         <span class="headingEndMark">
          —
         </span>
         Due to the rarity of this tumor, there are no large studies available to examine outcomes related to the extent of lymph node dissection [
         <a href="#rid28">
          28,29
         </a>
         ]. However, since lymph node metastases are common with gastric carcinoid, a lymph node dissection should be performed as with gastric carcinoma [
         <a href="#rid30">
          30,31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2615.html" rel="external">
          "Staging, treatment, and post-treatment surveillance of non-metastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors", section on 'Stomach'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465975745">
         <span class="h3">
          Prophylactic gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         During prophylactic total gastrectomy for those with
         <em>
          CDH1
         </em>
         mutation, only those lymph nodes that are harvested with the gastrectomy specimen are removed. A formal lymph node dissection is not needed. (See
         <a class="medical medical_review" href="/z/d/html/8041.html" rel="external">
          "Surgical management of hereditary diffuse gastric cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1085808238">
         <span class="h2">
          Adjacent organ resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unless there is direct tumor extension or lymph node metastasis, splenectomy, pancreatectomy, or bursectomy should
         <strong>
          not
         </strong>
         be performed routinely with total gastrectomy [
         <a href="#rid32">
          32
         </a>
         ]. As discussed in this section, there is good evidence that performing such adjacent organ resection increases the morbidity and mortality of total gastrectomy without improving survival.
        </p>
        <p class="headingAnchor" id="H1972161344">
         <span class="h3">
          Splenectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Splenectomy used to be performed in Japan as a part of total gastrectomy for proximal gastric cancer to facilitate complete lymphadenectomy at the splenic hilum. However, it can add to the morbidities (54 percent) and mortality (16 percent) of gastric cancer surgery and was thought to mask the benefit of D2 lymphadenectomy in early trials [
         <a href="#rid33">
          33
         </a>
         ]. In the JCOG 0110 trial, which included 505 patients undergoing total gastrectomy for proximal gastric cancer, splenectomy was associated with a high morbidity (30.3 percent) but low mortality (0.4 percent) and did not improve five-year overall survival (75.1 percent splenectomy versus 76.4 percent no splenectomy) or five-year recurrence-free survival (68.4 versus 70.5 percent) [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4131645722">
         <span class="h3">
          Distal pancreatectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Similar to splenectomy, the purpose of performing a distal pancreatectomy with total gastrectomy is to ensure a complete D2 lymphadenectomy. However, pancreatectomy was associated with high morbidity and mortality rates in early trials and thus diminishing purported oncologic benefits [
         <a href="#rid35">
          35,36
         </a>
         ]. In a trial of 110 patients under total gastrectomy with D2 dissection, patients who underwent pancreatectomy and splenectomy had higher morbidity (eg, diabetes) and mortality rates than those who underwent splenectomy alone but no five-year overall survival benefit [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19905649">
         <span class="h3">
          Bursectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A bursectomy is a dissection of the peritoneal lining covering the pancreas and the anterior aspect of the transverse mesocolon. It was mainly performed to remove possible free cancer cells or micrometastasis, especially for posterior gastric cancer that invades the serosa [
         <a href="#rid38">
          38
         </a>
         ]. A trial (JCOG 1001) that included 1204 patients with cT3-4 did not find a benefit for bursectomy in five-year overall survival, recurrence-free survival, or recurrence rate [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H87994226">
         <span class="h2">
          Vagus nerve preservation
         </span>
         <span class="headingEndMark">
          —
         </span>
         During skeletonization of the distal esophagus, hepatic and celiac branches of the anterior and posterior vagal nerves, respectively, should be preserved. In a systematic review and meta-analysis of seven retrospective comparative studies and one trial, gastrectomy with preservation of the celiac and hepatic branches of the vagus nerve reduced the time to first flatus (weighted mean difference -0.436, 95% CI -0.603 to -0.269) and hospital stay (weighted mean difference -0.456, 95% CI -0.874 to -0.037) compared with not preserving those nerves. Nerve preservation was also associated with a lower incidence of gallstones (odds ratio 0.582, 95% CI 0.356-0.953) and a lower incidence of bile reflux (odds ratio 0.473, 95% CI 0.280-0.800) but not rates of diarrhea, early dumping syndrome, esophageal reflux, and delayed gastric emptying [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="local">
          'Total gastrectomy'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications", section on 'Postvagotomy diarrhea'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465975649">
         <span class="h1">
          PROCEDURE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once the abdomen has been entered, total gastrectomy is performed by exposing and isolating the stomach, then dividing the esophagus and proximal duodenum and removing the specimen. Surgical margins are evaluated with frozen section, as indicated, and, if clear, reconstruction is undertaken to restore gastrointestinal continuity. (See
         <a class="local">
          'Margins of resection'
         </a>
         above and
         <a class="local">
          'Gastrointestinal reconstruction'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4294530746">
         <span class="h2">
          Incision
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because a thoracotomy may be needed to obtain a clear proximal margin, the patient should be prepared and draped for that possibility. An upper abdominal midline incision from the xiphoid process of the sternum to the umbilicus is generally adequate. Alternatively, a bilateral subcostal (ie, chevron) incision may be used with similar exposure. (See
         <a class="medical medical_review" href="/z/d/html/2.html" rel="external">
          "Incisions for open abdominal surgery"
         </a>
         .)
        </p>
        <p>
         Once the abdomen is entered, the left triangular ligament of the liver should be taken down. A self-retaining retractor (eg, Thompson, Omni) can be used to retract the upper abdominal wall and left lateral lobe of the liver to provide better exposure of hiatus and the gastroesophageal junction.
        </p>
        <p class="headingAnchor" id="H87994121">
         <span class="h2">
          Total gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         To resect the stomach:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Take the greater omentum off the transverse colon and mesocolon inferiorly to resect the omentum with the stomach en bloc when managing gastric carcinoma (
         <a class="graphic graphic_figure graphicRef53153" href="/z/d/graphic/53153.html" rel="external">
          figure 4
         </a>
         ). For prophylactic gastrectomy, the greater omentum can be preserved with the transverse mesocolon inferiorly (
         <a class="graphic graphic_figure graphicRef93407" href="/z/d/graphic/93407.html" rel="external">
          figure 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identify the pylorus (
         <a class="graphic graphic_figure graphicRef58218" href="/z/d/graphic/58218.html" rel="external">
          figure 6
         </a>
         ) and mark it with a suture (eg, 3-0 Prolene).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ligate the right gastric and right gastroepiploic vessels at their base (
         <a class="graphic graphic_figure graphicRef58218" href="/z/d/graphic/58218.html" rel="external">
          figure 6
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transect the duodenum distal to the pylorus using a gastrointestinal anastomosis (GIA) stapler (
         <a class="graphic graphic_figure graphicRef81584" href="/z/d/graphic/81584.html" rel="external">
          figure 7
         </a>
         ). Care is taken to avoid injury to biliary and portal structures. Some surgeons also imbricate the staple line of the duodenal stump to prevent a duodenal stump leak. (See
         <a class="medical medical_review" href="/z/d/html/15168.html" rel="external">
          "Postgastrectomy duodenal leak", section on 'Prevention'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Continue the dissection cephalad along the lesser curvature of the stomach by dividing and ligating the gastrohepatic ligament toward the diaphragm (
         <a class="graphic graphic_figure graphicRef81369" href="/z/d/graphic/81369.html" rel="external">
          figure 8
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identify and divide the left gastric vessels (
         <a class="graphic graphic_figure graphicRef81369" href="/z/d/graphic/81369.html" rel="external">
          figure 8
         </a>
         ). Dissect along the greater curvature of the stomach just outside the gastroepiploic arcade.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Encircle the esophagus with a Penrose drain and divide each crus of the diaphragm. Skeletonize the distal esophagus but preserve the hepatic and celiac branches of the anterior and posterior vagus without compromising an adequate nodal dissection if the surgeon is familiar with the technique. Place four stay sutures (eg, 2-0 Prolene) circumferentially in the esophagus approximately 2 cm proximal to the presumed gastroesophageal junction. (See
         <a class="local">
          'Vagus nerve preservation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transect the distal esophagus using a pursestring device (
         <a class="graphic graphic_figure graphicRef71227" href="/z/d/graphic/71227.html" rel="external">
          figure 9
         </a>
         ). Place the anvil of the end-to-end anastomosis (EEA) stapler into the distal esophagus, which will be used to create the esophagojejunal anastomosis, and tighten the pursestring suture. (See
         <a class="local">
          'Gastrointestinal reconstruction'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         As an alternative to the last two steps, the distal esophagus may be divided with a GIA stapler, and the anvil of the EEA stapler can be introduced across the GIA staple line via a specialized nasogastric tube introduced orally (eg, OrVil device). In this instance, stay sutures may be omitted. A handsewn anastomosis is technically more difficult and therefore only done rarely when a stapled anastomosis is not feasible [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H465975840">
         <span class="h2">
          Gastrointestinal reconstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal method of reconstruction after total gastrectomy would provide for a functional reservoir, preserve duodenal and jejunal continuity, and minimize postgastrectomy functional disturbance [
         <a href="#rid42">
          42
         </a>
         ]. No one reconstruction technique fulfills all these criteria; however, Roux-en-Y esophagojejunostomy with a jejunal pouch appears to have better functional outcomes and improved quality of life compared with other types of reconstruction in the short term [
         <a href="#rid43">
          43-49
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3248365825">
         <span class="h3">
          Reconstruction options
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most commonly performed gastrointestinal reconstructive procedure after a total gastrectomy is Roux-en-Y esophagojejunostomy with or without a jejunal pouch. Less commonly performed procedures include jejunal interposition, colon interposition, and looped esophagojejunal anastomosis [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Roux-en-Y esophagojejunostomy
         </strong>
         – After total gastrectomy, a direct esophagus-to-duodenum anastomosis (Billroth I) is anatomically difficult. A loop esophagojejunostomy (Billroth II) is rarely performed because of bile reflux. Thus, Roux-en-Y esophagojejunostomy (
         <a class="graphic graphic_figure graphicRef63448" href="/z/d/graphic/63448.html" rel="external">
          figure 10
         </a>
         ) is the preferred reconstruction after total gastrectomy [
         <a href="#rid50">
          50
         </a>
         ]. The Roux limb can be positioned antecolic or retrocolic (through transverse mesocolon) but needs to be sufficiently long (about 50 cm) to prevent bile reflux [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Jejunal pouch
         </strong>
         – The loss of the gastric reservoir is an important reason that patients lose about 10 percent of their body weight over the first three to six months [
         <a href="#rid42">
          42
         </a>
         ]. The gastric reservoir lost to total gastrectomy is most often replaced during reconstruction with a jejunal pouch. The benefit of jejunal pouches are most pronounced during the early postoperative months, when they increase food intake; the advantage over simple reconstruction diminishes over time, yet patients still report a better quality of life with the pouch [
         <a href="#rid42">
          42,50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A meta-analysis pooled the outcomes of 17 randomized trials and 8 observational studies involving 1621 participants and associated jejunal pouch reconstruction with a significantly decreased incidence of esophagitis and heartburn (6 versus 16 percent), dumping syndrome (5 versus 26 percent), and food intake disturbance (14 versus 44 percent) at one to two years [
         <a href="#rid43">
          43
         </a>
         ]. Albumin levels and body mass index were also higher among pouch patients in the same time frame. Pouch reconstruction increased operation time slightly (259 versus 236 minutes) but did not increase morbidity or mortality or length of hospital stay.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Jejunal pouches vary in size (5 to 20 cm), configuration (J, omega, S), and location (proximal or distal). Jejunal pouches can be added to both Roux-en-Y reconstruction and jejunal interposition. The choice of a particular type of pouch is determined by surgeon preference [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other reconstruction options
         </strong>
         – Jejunal interposition and ileocolonic interposition have been studied in the past but have fallen out of favor due to lack of evidence of benefit.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A jejunal interposition preserves the anterograde duodenal transit, which is more physiological and in theory could improve postoperative nutrition. However, a number of older trials [
         <a href="#rid42">
          42
         </a>
         ] and contemporary studies [
         <a href="#rid50">
          50
         </a>
         ] fail to demonstrate any advantage for jejunal interposition in weight loss or quality of life. Jejunal interposition is also associated with the disadvantages of longer operative time (by 15 to 40 minutes), the risk of an additional anastomosis, and potential for greater bile reflux or becoming involved in cancer recurrence [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         An ileocolonic interposition reconstructs the alimentary tract after total gastrectomy by placing a pedicled ileocecal interposition graft between the esophagus and the duodenum [
         <a href="#rid52">
          52
         </a>
         ]. It does have the disadvantage of an additional colonic anastomosis [
         <a href="#rid53">
          53
         </a>
         ]. It has not been compared with other methods of reconstruction in randomized trials
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H784312705">
         <span class="h3">
          Roux-en-Y esophagojejunostomy with Hunt-Lawrence pouch
         </span>
         <span class="headingEndMark">
          —
         </span>
         We prefer to use a Hunt-Lawrence type pouch with a Roux-en-Y reconstruction (
         <a class="graphic graphic_figure graphicRef76731" href="/z/d/graphic/76731.html" rel="external">
          figure 11
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transect the jejunum distal to the ligament of Treitz. Bring the jejunal loop anterior to the colon up to the esophagus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fold the jejunum back onto itself, placing traction sutures along the antimesenteric border of the jejunum to hold the limbs together. The optimal length of the pouch has not been well studied. One small trial found that 13 patients with a 9 cm pouch were better able to eat at their preoperative intake level and maintain body weight compared with 14 patients who had a 12 cm pouch [
         <a href="#rid54">
          54
         </a>
         ]. We make the pouch approximately 10 cm. Pouches that are too long may lead to distension, elongation, or blind loop syndrome.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Make an incision in each loop caudally, and fire a GIA stapling device to create a side-to-side anastomosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use an EEA circular stapling device to create the anastomosis between the pouch and the esophagus. Introduce the long arm of the EEA stapler through the pouch, open the stapler to push the center post through the proximal pouch, using a scalpel or electrocautery to complete the opening. Place a pursestring suture around the pin, and pull to snug the tissue around the post. Connect the posts of the long arm and anvil of the EEA device. Close the device, firmly apposing the esophageal and jejunal tissue, and fire. Gently pull the EEA anvil through the anastomosis and remove the device from the pouch.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Close the caudal pouch opening transversely using a TA or GIA stapling device.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anastomose the proximal jejunum to the efferent limb of the pouch in an end-to-side fashion 20 cm distal to the caudal end of the pouch. We generally fashion a stapled anastomosis, but a handsewn technique can also be used; either option is equally effective.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We do
         <strong>
          not
         </strong>
         place a nasojejunal tube through the anastomoses. Modern enhanced recovery after surgery (ERAS) protocols do not call for routine use of nasogastric or nasojejunal tubes after gastric surgery [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H87994375">
         <span class="h2">
          Feeding jejunostomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A jejunal feeding tube may be placed approximately 20 cm distal to the Roux-en-Y jejuno-jejunostomy in patients with preoperative weight loss or other risk factors for complicated or delayed recovery. We create a Stamm-type jejunostomy using a 14 Fr T-tube, secured with a double pursestring (3-0 absorbable suture) and anchored to the anterior abdominal wall (
         <a class="graphic graphic_figure graphicRef76417" href="/z/d/graphic/76417.html" rel="external">
          figure 12
         </a>
         ).
        </p>
        <p>
         The feeding tube provides enteral access for early enteral feeding, as well as delivery of enterally administered medications in the postoperative period, and can be used for prolonged access in those who develop complications. The routine use of jejunal feeding tubes, however, is controversial since there are conflicting data as to whether it increases or decreases the morbidity of the procedure [
         <a href="#rid55">
          55-57
         </a>
         ]. Contemporary ERAS protocols do not support their use, but they can be considered in select cases where patients may be at elevated risk of postoperative eating challenges. (See
         <a class="local">
          'Perioperative nutritional support'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H465974040">
         <span class="h1">
          POSTOPERATIVE MANAGEMENT AND FOLLOW-UP
         </span>
        </p>
        <p class="headingAnchor" id="H465974047">
         <span class="h2">
          Perioperative nutritional support
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients are initially maintained on intravenous fluids and are not given anything to eat by mouth (ie, nil per os [NPO]). If a jejunostomy tube is placed during the operation, then this allows for early postoperative enteral feeding while the patient is NPO. Tube feeding can be initiated two to three days postoperatively and advanced according to the patient's tolerance. The presence of a postoperative ileus may limit the tolerance to tube feeding, particularly in the first days after surgery. (See
         <a class="medical medical_review" href="/z/d/html/2880.html" rel="external">
          "Overview of perioperative nutrition support", section on 'Early enteral feeding'
         </a>
         .)
        </p>
        <p>
         We obtain a Gastrografin swallowing study between postoperative days three and five to evaluate the esophagojejunal anastomosis for leak prior to initiating an oral diet. However, practices vary, and there is some evidence that an oral diet may be initiated as early as the first postoperative day after a total gastrectomy [
         <a href="#rid3">
          3
         </a>
         ]. Obviously, the initiation of oral diet would be influenced by the overall condition of the patient, chronic comorbidities, and how well the operation went.
        </p>
        <p>
         In the absence of anastomotic leak on Gastrografin swallow, we start a liquid diet and advance to a soft diet over 24 to 48 hours. Small, frequent meals, high in protein and inclusive of fat, should be consumed approximately six times per day. Liquids may need to be taken separately from solids. Meals high in simple carbohydrates may contribute to dumping syndrome and may need to be avoided. (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications", section on 'Dumping syndrome'
         </a>
         .)
        </p>
        <p>
         Alteration in dietary intake and weight loss are to be anticipated with this procedure. Close involvement with a dietitian familiar with postgastrectomy patients is advisable to help patients adjust to their new dietary regimen and minimize weight loss. Vitamin and mineral supplementation are also required.
        </p>
        <p class="headingAnchor" id="H465975905">
         <span class="h2">
          Follow-up
         </span>
         <span class="headingEndMark">
          —
         </span>
         Schedules of follow-up after total gastrectomy vary by indication. The suggested postgastrectomy surveillance for gastric cancer is presented in another topic. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Post-treatment surveillance'
         </a>
         .)
        </p>
        <p>
         Routine surveillance endoscopy is not necessary. Endoscopy is appropriate when symptoms warrant investigation. Locoregional recurrence of adenocarcinoma in the setting of total gastrectomy is almost universally fatal, and there is no evidence that early detection of recurrence prolongs life.
        </p>
        <p class="headingAnchor" id="H465974054">
         <span class="h1">
          PERIOPERATIVE MORBIDITY AND MORTALITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of perioperative death from gastrectomy is associated with patient age and extent of lymph node dissection. Patient nutritional status and neoadjuvant therapy may also be a factor. In contemporary series, perioperative mortality rates range from 2 to 4 percent [
         <a href="#rid58">
          58,59
         </a>
         ].
        </p>
        <p>
         Perioperative morbidity rate ranges from 21 to 44 percent, depending on the length of follow-up and the definition of morbidities [
         <a href="#rid58">
          58,59
         </a>
         ]. Perioperative surgical complications following total gastrectomy are primarily due to the consequences of anastomotic leak. Long-term surgical complications include late esophageal stricture and postgastrectomy syndromes.
        </p>
        <p class="headingAnchor" id="H465976045">
         <span class="h2">
          Anastomotic complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disruption of the esophagojejunal anastomosis is the most worrisome complication in the early postoperative period. The jejunojejunal anastomosis is rarely a problem. Various groups have reported esophageal leak rates of 5 to 7 percent [
         <a href="#rid59">
          59,60
         </a>
         ]. Minor leaks without systemic sepsis can be managed conservatively with antibiotics, intestinal decompression, and percutaneous drainage of any associated fluid collections or abscess. Intestinal decompression in the absence of the stomach is accomplished using a nasojejunal tube placed distal to the esophageal anastomosis, typically using fluoroscopic guidance. A covered stent across the anastomosis may also be applied with good effect [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
         Major disruption that requires reoperation is fraught with difficulties and is associated with increased mortality. Overall, disruption of the esophagojejunal anastomosis is associated with poorer survival (hazard ratio 3.47, 95% CI 1.82-6.64) [
         <a href="#rid62">
          62
         </a>
         ]. The occurrence of anastomotic leak also increases the risk for subsequent anastomotic stricture.
        </p>
        <p>
         Stricture of the esophagojejunostomy is reported in approximately 4 percent of patients [
         <a href="#rid63">
          63
         </a>
         ]. The rate of stricture can be affected by the anastomotic technique (eg, handsewn versus stapled; end-to-end anastomosis stapler versus linear stapler) [
         <a href="#rid64">
          64-66
         </a>
         ], but there is no conclusive evidence that one technique is superior to others. Patients with anastomotic stricture will usually present with dysphagia. Upper endoscopy can diagnose the stricture, which can be also be dilated endoscopically, usually with good results; however, repeated sessions may be needed.
        </p>
        <p class="headingAnchor" id="H465976067">
         <span class="h2">
          Postgastrectomy syndromes
         </span>
         <span class="headingEndMark">
          —
         </span>
         A 10 to 15 percent decrease in body weight and postgastrectomy syndromes are common sequelae of total gastrectomy [
         <a href="#rid2">
          2,67,68
         </a>
         ]. The dumping syndrome and diarrhea are most severe in the initial postoperative period and generally improve within 12 months [
         <a href="#rid69">
          69
         </a>
         ]. Postgastrectomy complications are discussed in detail in another topic. (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5945149">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/134311.html" rel="external">
          "Society guideline links: Gastric surgery for cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465974068">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications and contraindications for total gastrectomy
         </strong>
         – The term "total gastrectomy" implies the complete removal of all gastric tissue. Total gastrectomy is the treatment of choice for certain malignancies of the proximal stomach, diffuse signet ring gastric adenocarcinoma, and hereditary diffuse gastric cancer (cadherin-1 [
         <em>
          CDH1
         </em>
         ] mutation), both in the prophylactic setting and when invasive gastric cancer has been confirmed. Benign indications for total gastrectomy are rare but may include hemorrhagic gastritis and intractable symptoms in patients who have undergone prior partial gastrectomy. Metastatic disease and severe medical comorbidities contraindicate total gastrectomy. (See
         <a class="local">
          'Indications'
         </a>
         above and
         <a class="local">
          'Contraindications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative staging
         </strong>
         – Patients undergoing total gastrectomy for malignancy should undergo preoperative staging to rule out metastatic disease, including computed tomography (CT) of the abdomen and upper endoscopy. Staging laparoscopy may be indicated for patients with locally advanced gastric adenocarcinoma. (See
         <a class="local">
          'Tumor staging'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Staging evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgical prophylaxis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Prophylactic antibiotics
         </strong>
         – All patients undergoing total gastrectomy should receive intravenous antibiotic prophylaxis (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ). Mechanical bowel preparation is not necessary. (See
         <a class="local">
          'Antibiotics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Thromboprophylaxis
         </strong>
         – All patients undergoing total gastrectomy for malignancy should receive pharmacologic prophylaxis and mechanical prophylaxis with intermittent pneumatic compression. (See
         <a class="local">
          'Thromboprophylaxis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Procedure
         </strong>
         – Total gastrectomy is accomplished by exposing and isolating the stomach, dividing the esophagus and proximal duodenum, removing the specimen, and then restoring gastrointestinal continuity. (See
         <a class="local">
          'Procedure'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Margins
         </strong>
         – For most patients undergoing total gastrectomy, we obtain intraoperative frozen sections of the proximal and/or distal margins. For adenocarcinoma, the margins should be clear of tumor. For patients undergoing prophylactic gastrectomy, the proximal margin should be clear of gastric mucosa. (See
         <a class="local">
          'Margins of resection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Lymphadenectomy
         </strong>
         – For patients undergoing total gastrectomy for gastric adenocarcinoma or carcinoid, we suggest a D2 lymphadenectomy without splenectomy, rather than a lesser (D1) or greater amount (D3) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). For patients undergoing prophylactic gastrectomy for
         <em>
          CDH1
         </em>
         mutation, gastrointestinal stromal tumors (GISTs), or the rare instance of total gastrectomy for benign reasons, formal lymphadenectomy is not needed. (See
         <a class="local">
          'Extent of nodal dissection'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Extent of lymph node dissection'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Vagus nerve sparing
         </strong>
         – Whenever possible, we suggest preserving the hepatic branch of the anterior vagus nerve and the celiac branch of the posterior vagus nerve, rather than sacrificing these nerves with the specimen (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Vagus nerve preservation minimizes the incidence of gallstone formation and diarrhea, which can occur in patients who undergo truncal vagotomy. (See
         <a class="local">
          'Vagus nerve preservation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Reconstruction
         </strong>
         – After total gastrectomy, we suggest an esophagojejunostomy with a jejunal pouch reconstruction rather than other reconstructive methods (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). Jejunal pouch reconstruction improves postoperative quality of life. We prefer the Hunt-Lawrence type of jejunal pouch, but the pouch size and design are surgeon preference. (See
         <a class="local">
          'Gastrointestinal reconstruction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postoperative care
         </strong>
         – Postoperatively, the patient is maintained on intravenous fluids. Oral and enteral feeding can be introduced postoperatively in a tailored fashion depending on whether an enhanced recovery after surgery (ERAS) protocol is followed and upper gastrointestinal contrast study is obtained, and whether a jejunal feeding tube has been placed. (See
         <a class="local">
          'Postoperative management and follow-up'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Outcomes
         </strong>
         – Perioperative mortality rates following total gastrectomy range between 2 and 4 percent, depending upon patient age and extent of lymph node dissection. Perioperative surgical complications following total gastrectomy are primarily due to the consequences of anastomotic leak, which occurs in 5 to 7 percent of patients. Long-term surgical complications include late esophageal stricture and postgastrectomy syndromes. (See
         <a class="local">
          'Perioperative morbidity and mortality'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2228404558">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Debrah Wirtzfeld, MD, MSc, FRCSC, FACS, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol 2016; 17:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kubota T, Shoda K, Konishi H, et al. Nutrition update in gastric cancer surgery. Ann Gastroenterol Surg 2020; 4:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mortensen K, Nilsson M, Slim K, et al. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Br J Surg 2014; 101:1209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lynch HT, Kaurah P, Wirtzfeld D, et al. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer 2008; 112:2655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer 2012; 15 Suppl 1:S38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon M, Cardoso R, Tinmouth J, et al. What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel. Gastric Cancer 2014; 17:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holthöfer H. Ontogeny of cell type-specific enzyme reactivities in kidney collecting ducts. Pediatr Res 1987; 22:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol 2020; 18:534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imamura H, Kurokawa Y, Tsujinaka T, et al. Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trial. Lancet Infect Dis 2012; 12:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohri Y, Tonouchi H, Kobayashi M, et al. Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery. Br J Surg 2007; 94:683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schardey HM, Joosten U, Finke U, et al. The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 1997; 225:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farran L, Llop J, Sans M, et al. Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery. Dis Esophagus 2008; 21:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schardey J, von Ahnen T, Schardey E, et al. Antibiotic Bowel Decontamination in Gastrointestinal Surgery-A Single-Center 20 Years' Experience. Front Surg 2022; 9:874223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Best LM, Mughal M, Gurusamy KS. Laparoscopic versus open gastrectomy for gastric cancer. Cochrane Database Syst Rev 2016; 3:CD011389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lei X, Wang Y, Shan F, et al. Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials. World J Surg Oncol 2022; 20:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer 2023; 26:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang FH, Zhang XT, Li YF, et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021; 41:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2022; 33:1005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang Z, Liu C, Cai Z, et al. Impact of Surgical Margin Status on Survival in Gastric Cancer: A Systematic Review and Meta-Analysis. Cancer Control 2021; 28:10732748211043665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22:2767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kulig J, Popiela T, Kolodziejczyk P, et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007; 193:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yonemura Y, Wu CC, Fukushima N, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 2008; 13:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ajani JA, D'Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2022; 20:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Köseoğlu H, Duzenli T, Sezikli M. Gastric neuroendocrine neoplasms: A review. World J Clin Cases 2021; 9:7973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol 2020; 12:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delle Fave G, O'Toole D, Sundin A, et al. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology 2016; 103:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kunz PL, Reidy-Lagunes D, Anthony LB, et al. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas 2013; 42:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiyokawa T, Fukagawa T. Recent trends from the results of clinical trials on gastric cancer surgery. Cancer Commun (Lond) 2019; 39:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347:995.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sano T, Sasako M, Mizusawa J, et al. Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. Ann Surg 2017; 265:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79:1522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22:2069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furukawa H, Hiratsuka M, Ishikawa O, et al. Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method. Ann Surg Oncol 2000; 7:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujita J, Kurokawa Y, Sugimoto T, et al. Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer 2012; 15:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurokawa Y, Doki Y, Mizusawa J, et al. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol 2018; 3:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jin T, Chen ZH, Liang PP, et al. A Gastrectomy for early-stage gastric cancer patients with or without preserving celiac branches of vagus nerves: A meta-analysis. Surgery 2023; 173:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Honório FCC, Tustumi F, Pinheiro Filho JEL, et al. Esophagojejunostomy after total gastrectomy: A systematic review and meta-analysis comparing hand-sewn and stapled anastomosis. J Surg Oncol 2022; 126:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lehnert T, Buhl K. Techniques of reconstruction after total gastrectomy for cancer. Br J Surg 2004; 91:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Syn NL, Wee I, Shabbir A, et al. Pouch Versus No Pouch Following Total Gastrectomy: Meta-analysis of Randomized and Non-randomized Studies. Ann Surg 2019; 269:1041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menon P, Sunil I, Chowdhury SK, Rao KL. Hunt-Lawrence pouch after total gastrectomy: 4 years follow up. Indian Pediatr 2003; 40:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           HUNT CJ. Construction of food pouch from segment of jejunum as substitute for stomach in total gastrectomy. AMA Arch Surg 1952; 64:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LAWRENCE W Jr. Reservoir construction after total gastrectomy: an instructive case. Ann Surg 1962; 155:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawrence W Jr. Reconstruction after total gastrectomy: what is preferred technique? J Surg Oncol 1996; 63:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El Halabi HM, Lawrence W Jr. Clinical results of various reconstructions employed after total gastrectomy. J Surg Oncol 2008; 97:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piessen G, Triboulet JP, Mariette C. Reconstruction after gastrectomy: which technique is best? J Visc Surg 2010; 147:e273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naum C, Bîrlă R, Marica DC, Constantinoiu S. In Search of the Optimal Reconstruction Method after Total Gastrectomy. Is Roux-en-Y the Best? A Review of the Randomized Clinical Trials. Chirurgia (Bucur) 2020; 115:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matei D, Dadu R, Prundus R, et al. Alkaline reflux esophagitis in patients with total gastrectomy and Roux en Y esojejunostomy. J Gastrointestin Liver Dis 2010; 19:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LEE CM Jr. Transposition of a colon segment as a gastric reservoir after total gastrectomy. Surg Gynecol Obstet 1951; 92:456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakamoto T, Fujimaki M, Tazawa K. Ileocolon interposition as a substitute stomach after total or proximal gastrectomy. Ann Surg 1997; 226:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsujimoto H, Sakamoto N, Ichikura T, et al. Optimal size of jejunal pouch as a reservoir after total gastrectomy: a single-center prospective randomized study. J Gastrointest Surg 2011; 15:1777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun Z, Shenoi MM, Nussbaum DP, et al. Feeding jejunostomy tube placement during resection of gastric cancers. J Surg Res 2016; 200:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dann GC, Squires MH 3rd, Postlewait LM, et al. An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative. J Surg Oncol 2015; 112:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel SH, Kooby DA, Staley CA 3rd, Maithel SK. An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma. J Surg Oncol 2013; 107:728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brisinda G, Chiarello MM, Crocco A, et al. Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study. World J Gastroenterol 2022; 28:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li SS, Costantino CL, Mullen JT. Morbidity and Mortality of Total Gastrectomy: a Comprehensive Analysis of 90-Day Outcomes. J Gastrointest Surg 2019; 23:1340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lang H, Piso P, Stukenborg C, et al. Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma. Eur J Surg Oncol 2000; 26:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee SR, Kim HO, Park JH, Yoo CH. Clinical Outcomes of Endoscopic Metal Stent Placement for Esophagojejunostomy Leakage After Total Gastrectomy for Gastric Adenocarcinoma. Surg Laparosc Endosc Percutan Tech 2018; 28:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sierzega M, Kolodziejczyk P, Kulig J, Polish Gastric Cancer Study Group. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg 2010; 97:1035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukagawa T, Gotoda T, Oda I, et al. Stenosis of esophago-jejuno anastomosis after gastric surgery. World J Surg 2010; 34:1859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Majewska K, Zemła P, Jabłońska B, Mrowiec S. Comparison of Postoperative Outcomes of Hand-Sewn Versus Stapled Esophago-jejunal Anastomosis During Total Gastrectomy for Gastric Cancer in 72 Patients: A Retrospective, Single-Center Study in Poland. Med Sci Monit 2023; 29:e938759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muneoka Y, Ohashi M, Makuuchi R, et al. Advantageous Short-Term Outcomes of Esophagojejunostomy Using a Linear Stapler Following Open Total Gastrectomy Compared with a Circular Stapler. World J Surg 2021; 45:2501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nomura E, Kayano H, Seki T, et al. Preventive procedure for stenosis after esophagojejunostomy using a circular stapler and transorally inserted anvil (OrVil™) following laparoscopic proximal gastrectomy and total gastrectomy involving reduction of anastomotic tension. BMC Surg 2021; 21:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serra F, Pedrazzoli P, Brugnatelli S, et al. Nutritional support management in resectable gastric cancer. Drugs Context 2022; 11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davis JL, Ripley RT. Postgastrectomy Syndromes and Nutritional Considerations Following Gastric Surgery. Surg Clin North Am 2017; 97:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu Y, Zaydfudim VM. Quality of Life After Curative Resection for Gastric Cancer: Survey Metrics and Implications of Surgical Technique. J Surg Res 2020; 251:168.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15166 Version 21.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26822397" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32724879" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Nutrition update in gastric cancer surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25047143" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18442100" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21667136" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23633230" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2825108" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Ontogeny of cell type-specific enzyme reactivities in kidney collecting ducts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31362118" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Burden of Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19216670" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15227616" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22297080" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17514671" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9065294" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18269652" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35651691" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Antibiotic Bowel Decontamination in Gastrointestinal Surgery-A Single-Center 20 Years' Experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27030300" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Laparoscopic versus open gastrectomy for gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36566193" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36342574" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34197702" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35914639" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34569315" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Impact of Surgical Margin Status on Survival in Gastric Cancer: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20409751" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15199090" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17188080" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18463957" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18669424" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35130500" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34621854" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Gastric neuroendocrine neoplasms: A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32879660" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Gastrointestinal neuroendocrine tumors in 2020.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26784901" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23591432" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Consensus guidelines for the management and treatment of neuroendocrine tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30917873" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Recent trends from the results of clinical trials on gastric cancer surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8606613" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27280511" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10188901" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15082726" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11034244" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21573917" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29709558" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36379744" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A Gastrectomy for early-stage gastric cancer patients with or without preserving celiac branches of vagus nerves: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35689590" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Esophagojejunostomy after total gastrectomy: A systematic review and meta-analysis comparing hand-sewn and stapled anastomosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15122602" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Techniques of reconstruction after total gastrectomy for cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31082900" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Pouch Versus No Pouch Following Total Gastrectomy: Meta-analysis of Randomized and Non-randomized Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12657760" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Hunt-Lawrence pouch after total gastrectomy: 4 years follow up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14923080" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Construction of food pouch from segment of jejunum as substitute for stomach in total gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14463011" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Reservoir construction after total gastrectomy: an instructive case.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8982364" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Reconstruction after total gastrectomy: what is preferred technique?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17963246" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Clinical results of various reconstructions employed after total gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20934934" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Reconstruction after gastrectomy: which technique is best?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32155396" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : In Search of the Optimal Reconstruction Method after Total Gastrectomy. Is Roux-en-Y the Best? A Review of the Randomized Clinical Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20922186" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Alkaline reflux esophagitis in patients with total gastrectomy and Roux en Y esojejunostomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14835202" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Transposition of a colon segment as a gastric reservoir after total gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9296506" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Ileocolon interposition as a substitute stomach after total or proximal gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21785918" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Optimal size of jejunal pouch as a reservoir after total gastrectomy: a single-center prospective randomized study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26248478" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Feeding jejunostomy tube placement during resection of gastric cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26240027" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23450704" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35110956" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31062268" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Morbidity and Mortality of Total Gastrectomy: a Comprehensive Analysis of 90-Day Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10744938" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29509565" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Clinical Outcomes of Endoscopic Metal Stent Placement for Esophagojejunostomy Leakage After Total Gastrectomy for Gastric Adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20632269" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20458580" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Stenosis of esophago-jejuno anastomosis after gastric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36698295" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Comparison of Postoperative Outcomes of Hand-Sewn Versus Stapled Esophago-jejunal Anastomosis During Total Gastrectomy for Gastric Cancer in 72 Patients: A Retrospective, Single-Center Study in Poland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33796923" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Advantageous Short-Term Outcomes of Esophagojejunostomy Using a Linear Stapler Following Open Total Gastrectomy Compared with a Circular Stapler.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33478457" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Preventive procedure for stenosis after esophagojejunostomy using a circular stapler and transorally inserted anvil (OrVil™) following laparoscopic proximal gastrectomy and total gastrectomy involving reduction of anastomotic tension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36339293" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Nutritional support management in resectable gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28325187" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Postgastrectomy Syndromes and Nutritional Considerations Following Gastric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32151826" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Quality of Life After Curative Resection for Gastric Cancer: Survey Metrics and Implications of Surgical Technique.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
